ERAMET S.A. (LON:0MGV)
47.98
-2.02 (-4.04%)
At close: Aug 1, 2025
Sage Therapeutics Market Cap
ERAMET has a market cap or net worth of 1.18 billion as of August 1, 2025. Its market cap has decreased by -46.98% in one year.
Market Cap
1.18B
Enterprise Value
3.31B
Revenue
2.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
$47.98
Market Cap Chart
Since December 15, 1994, ERAMET's market cap has increased from 593.25M to 1.18B, an increase of 98.60%. That is a compound annual growth rate of 2.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 1.18B | -7.52% |
Dec 31, 2024 | 1.27B | -28.06% |
Dec 29, 2023 | 1.77B | -10.34% |
Dec 30, 2022 | 1.98B | 13.96% |
Dec 31, 2021 | 1.73B | 70.35% |
Dec 31, 2020 | 1.02B | -1.30% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 172.19B |
HSBC Holdings | 159.16B |
Shell | 159.09B |
Unilever | 112.88B |
British American Tobacco p.l.c. | 90.29B |
Rolls-Royce Holdings | 89.59B |
Rio Tinto Group | 76.38B |
RELX PLC | 71.14B |